JPRN-jRCT2080222557UnknownPhase 2
Dose-finding study of AJG533 in patients with chronic constipation (Phase 2 study)
AJINOMOTO PHARMACEUTICALS CO.,LTD.0 sitesStarted: July 9, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to <= 74age old (—)
- Sex
- All
Inclusion Criteria
- •Patients with chronic constipation
Exclusion Criteria
- •Patient with known or suspected organic constipation
- •Patient with known or suspected symptomatic constipation or drug-induced constipation
Investigators
Similar Trials
Unknown
Phase 3
Phase 3 study of AJG533 in patients with chronic constipatioChronic constipationJPRN-jRCT2080223008EA Pharma Co.,Ltd.120
Unknown
Phase 3
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
Active, not recruiting
Phase 2
A phase II study of S-005151 in patients with chronic liver diseaseChronic liver disease - Liver cirrhosis (alcoholic, non-alcoholic, HBV, or HCV)D008103JPRN-jRCT2031200232Terai Shuji10
Unknown
Phase 2
A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type PsoriasispsoriasisJPRN-jRCT2080221043ovartis Pharma K.K.
Unknown
Phase 3
ong term study of AJG533 in patients with chronic constipatioChronic constipationJPRN-jRCT2080223007EA Pharma Co.,Ltd.360